LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Neratinib | 0.04 | uM | LJP5 | 2 | A18 | 72 | hr | 658 | 3333 | 3846 | 0.8666 | 0.8390 |
Hs 578T | Neratinib | 0.04 | uM | LJP5 | 3 | A18 | 72 | hr | 658 | 3601 | 3846 | 0.9363 | 0.9231 |
Hs 578T | Nilotinib | 0.04 | uM | LJP5 | 1 | N18 | 72 | hr | 658 | 4126 | 3846 | 1.0728 | 1.0878 |
Hs 578T | Nilotinib | 0.04 | uM | LJP5 | 2 | N18 | 72 | hr | 658 | 3952 | 3846 | 1.0275 | 1.0332 |
Hs 578T | Nilotinib | 0.04 | uM | LJP5 | 3 | N18 | 72 | hr | 658 | 4149 | 3846 | 1.0788 | 1.0950 |
Hs 578T | Nintedanib | 0.04 | uM | LJP6 | 1 | H06 | 72 | hr | 658 | 3524 | 3846 | 0.9163 | 0.8990 |
Hs 578T | Nintedanib | 0.04 | uM | LJP6 | 2 | H06 | 72 | hr | 658 | 3794 | 3846 | 0.9865 | 0.9837 |
Hs 578T | Nintedanib | 0.04 | uM | LJP6 | 3 | H06 | 72 | hr | 658 | 3350 | 3846 | 0.8710 | 0.8444 |
Hs 578T | NU7441 | 0.04 | uM | LJP5 | 1 | C12 | 72 | hr | 658 | 3705 | 3846 | 0.9633 | 0.9557 |
Hs 578T | NU7441 | 0.04 | uM | LJP5 | 2 | C12 | 72 | hr | 658 | 3686 | 3846 | 0.9584 | 0.9498 |
Hs 578T | NU7441 | 0.04 | uM | LJP5 | 3 | C12 | 72 | hr | 658 | 3887 | 3846 | 1.0106 | 1.0128 |
Hs 578T | Dactolisib | 0.04 | uM | LJP5 | 1 | M18 | 72 | hr | 658 | 1136 | 3846 | 0.2954 | 0.1499 |
Hs 578T | Dactolisib | 0.04 | uM | LJP5 | 2 | M18 | 72 | hr | 658 | 1144 | 3846 | 0.2974 | 0.1524 |
Hs 578T | Dactolisib | 0.04 | uM | LJP5 | 3 | M18 | 72 | hr | 658 | 1211 | 3846 | 0.3149 | 0.1734 |
Hs 578T | NVP-TAE684 | 0.04 | uM | LJP6 | 1 | K18 | 72 | hr | 658 | 2963 | 3846 | 0.7704 | 0.7230 |
Hs 578T | NVP-TAE684 | 0.04 | uM | LJP6 | 2 | K18 | 72 | hr | 658 | 3148 | 3846 | 0.8185 | 0.7810 |
Hs 578T | NVP-TAE684 | 0.04 | uM | LJP6 | 3 | K18 | 72 | hr | 658 | 3129 | 3846 | 0.8136 | 0.7751 |
Hs 578T | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 658 | 2388 | 3846 | 0.6209 | 0.5426 |
Hs 578T | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 658 | 2355 | 3846 | 0.6123 | 0.5323 |
Hs 578T | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 658 | 2341 | 3846 | 0.6087 | 0.5279 |
Hs 578T | PD0325901 | 0.04 | uM | LJP5 | 1 | C06 | 72 | hr | 658 | 2304 | 3846 | 0.5991 | 0.5163 |
Hs 578T | PD0325901 | 0.04 | uM | LJP5 | 2 | C06 | 72 | hr | 658 | 2392 | 3846 | 0.6219 | 0.5439 |
Hs 578T | PD0325901 | 0.04 | uM | LJP5 | 3 | C06 | 72 | hr | 658 | 2242 | 3846 | 0.5829 | 0.4968 |
Hs 578T | PD0325901 | 0.04 | uM | LJP6 | 1 | E06 | 72 | hr | 658 | 2165 | 3846 | 0.5629 | 0.4727 |
Hs 578T | PD0325901 | 0.04 | uM | LJP6 | 2 | E06 | 72 | hr | 658 | 2287 | 3846 | 0.5946 | 0.5109 |